S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

BACKGROUND: S-1 is an oral fluoropyrimidine whose antitumor effects have been demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer, when administered as monotherapy or in combination chemotherapy. We conducted a randomized phase III study investigating the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, M., Ishiguro, M., Ikejiri, K., Mochizuki, I., Nakamoto, Y., Kinugasa, Y., Takagane, A., Endo, T., Shinozaki, H., Takii, Y., Mochizuki, H., Kotake, K., Kameoka, S., Takahashi, K., Watanabe, T., Watanabe, M., Boku, N., Tomita, N., Nakatani, E., Sugihara, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143094/
https://www.ncbi.nlm.nih.gov/pubmed/24942277
http://dx.doi.org/10.1093/annonc/mdu232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143094/
https://www.ncbi.nlm.nih.gov/pubmed/24942277
http://dx.doi.org/10.1093/annonc/mdu232

Ejemplares similares